University of Toronto and McGill University scientists are leading an international partnership to discover new and improved drug treatments for tuberculosis, malaria and neglected tropical diseases  -- thanks to a contribution from Merck Canada Inc., as well as an additional $5 million supplement to a grant from the Bill & Melinda Gates Foundation. The new funding brings the total investment from the Bill & Melinda Gates Foundation to nearly US $12 million since 2012.

Classified as: medicine, health, tuberculosis, university of toronto, drug, health and lifestyle, Malaria, tropical diseases, Merck Canada, Bill & Melinda Gates Foundation, cryptosporidiosis, protozoan
Published on: 17 Dec 2015
Back to top